Delivery Order SPE2DB24D2101-SPE2DB24FKFFS

Award Date 7/16/24
Potential Completion Date 8/6/24
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,668.51 firm fixed-price delivery order contract is for the supply of the pharmaceutical product PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML. The contract has an ultimate completion date of December 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at up to $2,687.95, is for the delivery of PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of November 4, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,530.52 firm fixed-price contract is for the supply of the medication PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML. The contract has an ultimate completion date of March 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,075.18, is for the delivery of the specialty medication PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML. The contract has an ultimate completion date of December 5, 2024 and is a firm fixed-price delivery order. There is no set-aside designation noted for this award. AmerisourceBergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is a delivery order with a ceiling value of $1,075.18 for the supply of the pharmaceutical product PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML. The contract was awarded on September 23, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with an ultimate completion date of October 15, 2024. This award is not associated with a set-aside program and is a firm fixed-price contract. Amerisourcebergen, a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $3,530.52 firm fixed-price delivery order is for the supply of the pharmaceutical product PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,561.70 firm fixed-price delivery order contract is for the medical product "PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML" and has an ultimate completion date of January 15, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML, a pharmaceutical product, to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, on August 27, 2024 with a completion date of September 18, 2024. The contract has a firm fixed price and a ceiling value of $2,687.95. This award is not associated with any set-aside program....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Parsabiv medication vials. The contract has a ceiling value of $1,612.77 and an ultimate completion date of July 25, 2024. It is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,337.02 firm fixed-price contract is for the delivery of Parsabiv 2.5 mg/0.5 ml vials, a specialty medication. The contract has an ultimate completion date of December 19, 2024. Amerisourcebergen is an experienced federal contractor, holding a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB24FKFFS
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML, a prescription medication. The $3,225.54 firm-fixed-price Delivery Order has an ultimate completion date of August 6, 2024. This award is not associated with a set-aside program. Amerisourcebergen has significant Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation to supply a broad range of pharmaceutical and medical products to support military treatment programs, veterans' healthcare, and other federal healthcare initiatives nationwide.

Generated 10/15/24, 9:34 PM